Global Longlife Hospital and Research Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Global Longlife Hospital and Research Ltd?

Global Longlife Hospital and Research Ltd is trading at 14.30 as of 23 April 2026, with a FY2026-2027 high of 33.0 and low of 11.6. The stock is currently near its 52-week low. Market cap stands at 15.0 Cr..

Q: Is Global Longlife Hospital and Research Ltd financially healthy?

Key indicators: ROCE of 13.7 % is moderate. Dividend yield is 0.00 %.

Fair Value

₹52.65Undervalued by 268.18%vs CMP ₹14.30

P/E (15.0) × ROE (17.7%) × BV (₹24.30) × DY (2.00%)

Defaults: P/E=15

₹14.86Fairly Valued by 3.92%vs CMP ₹14.30

MoS: +3.8% (Thin)Confidence: 48/100 (Moderate)Models: 3 Under, 5 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹34.44	21%	Under (+140.8%)
Graham Number	Earnings	₹10.19	19%	Over (-28.7%)
Earnings Power	Earnings	₹0.58	12%	Over (-95.9%)
DCF	Cash Flow	₹1.88	15%	Over (-86.9%)
Net Asset Value	Assets	₹24.28	8%	Under (+69.8%)
Earnings Yield	Earnings	₹1.90	8%	Over (-86.7%)
ROCE Capital	Returns	₹32.25	10%	Under (+125.5%)
Revenue Multiple	Revenue	₹0.30	6%	Over (-97.9%)
Consensus (8 models)		₹14.86	100%	Fairly Valued

Key Drivers: EPS CAGR -34.6% drags value — could be higher if earnings stabilize. | Wide model spread (₹0–₹34) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -34.6% · Defaults: P/E=15

*Investments are subject to market risks

Analyst Summary

Global Longlife Hospital and Research Ltd operates in the Hospitals & Medical Services segment, NSE: GLHRL | BSE: 543520, current market price is ₹14.30, market cap is 15.0 Cr.. At a glance, ROE is 17.7 %, ROCE is 13.7 %, book value is 24.3, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹14.86, which is broadly in line with the current market price. On operating trend, latest reported sales are about ₹0 Cr versus the prior period change of -97.7%, while latest net profit is about ₹0 Cr with a prior-period change of 109.1%. The 52-week range shown on this page is 33.0/11.6, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisGlobal Longlife Hospital and Research Ltd. is a Public Limited Listed company incorporated on 20/01/2012 and has its registered office in the State of Gujarat, India. Company's Corporate Identificatio…

This summary is generated from the stock page data available for Global Longlife Hospital and Research Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Global Longlife Hospital and Research Ltd scores 42/100 (Weak)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health68/100 · Strong

ROCE 13.7% GoodROE 17.7% GoodD/E 0.91 ModerateInterest Coverage 0.0x RiskyProfitable 4/5 years Consistent

Smart Money35/100 · Weak

Promoter decreased by 19.66% Caution

Earnings Quality30/100 · Weak

OPM contracting (22% → -669%) DecliningWorking capital: 1,283 days Capital intensive

Quarterly Momentum15/100 · Weak

Revenue (4Q): -96% YoY DecliningProfit (4Q): -257% YoY DecliningOPM: 0.0% (down 22.0% YoY) Margin pressure

Industry Rank50/100 · Moderate

ROCE 13.7% vs industry 14.7% AverageROE 17.7% vs industry 13.9% Above peers3Y sales CAGR: -79% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:41 am

Market Cap	15.0 Cr.
Current Price	14.3
Intrinsic Value	₹14.86
High / Low	33.0/11.6
Stock P/E
Book Value	24.3
Dividend Yield	0.00 %
ROCE	13.7 %
ROE	17.7 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Global Longlife Hospital and Research Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
NG Industries Ltd	45.3 Cr.	135	180/114		117	2.59 %	5.69 %	0.99 %	10.0
Global Longlife Hospital and Research Ltd	15.0 Cr.	14.3	33.0/11.6		24.3	0.00 %	13.7 %	17.7 %	10.0
Gian Lifecare Ltd	6.50 Cr.	6.29	18.0/5.84		18.7	0.00 %	3.00 %	0.81 %	10.0
Fortis Malar Hospitals Ltd	85.4 Cr.	45.6	98.7/40.8	18.8	18.3	0.00 %	0.83 %	0.56 %	10.0
Family Care Hospitals Ltd	14.7 Cr.	2.72	5.83/2.55		1.51	0.00 %	79.2 %	85.5 %	10.0
Industry Average	26,819.31 Cr	611.59		75.17	83.71	0.36%	14.71%	13.91%	9.04

All Competitor Stocks of Global Longlife Hospital and Research Ltd

Quarterly Result

Metric	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025
Sales	19.94	12.87	11.80	11.70	12.33	1.18	0.58	0.00	0.00
Expenses	13.18	11.61	10.03	9.44	9.62	4.20	4.39	0.35	0.60
Operating Profit	6.76	1.26	1.77	2.26	2.71	-3.02	-3.81	-0.35	-0.60
OPM %	33.90%	9.79%	15.00%	19.32%	21.98%	-255.93%	-656.90%
Other Income	0.07	0.16	0.07	0.17	0.02	0.04	5.69	-0.67	0.01
Interest	0.09	1.31	0.20	0.20	0.41	0.36	0.28	0.00	0.00
Depreciation	0.58	0.57	0.58	0.59	0.61	0.64	0.48	0.00	0.00
Profit before tax	6.16	-0.46	1.06	1.64	1.71	-3.98	1.12	-1.02	-0.59
Tax %	0.00%	-78.26%	29.25%	35.37%	39.77%	-19.10%	-11.61%	2.94%	123.73%
Net Profit	6.17	-0.10	0.76	1.07	1.03	-3.22	1.24	-1.04	-1.32
EPS in Rs	8.81	-0.14	0.72	1.02	0.98	-3.07	1.18	-0.99	-1.26

Last Updated: January 8, 2026, 6:24 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 3:39 am

Metric	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	33.44	33.32	32.70	32.44	23.38	13.46	0.31	0.00
Expenses	26.61	29.88	27.26	24.14	19.30	13.68	4.45	0.95
Operating Profit	6.83	3.44	5.44	8.30	4.08	-0.22	-4.14	-0.95
OPM %	20.42%	10.32%	16.64%	25.59%	17.45%	-1.63%	-1,335.48%
Other Income	0.08	0.03	0.06	0.17	0.24	0.00	5.02	-0.66
Interest	2.07	2.41	2.44	1.62	0.45	0.80	0.30	0.00
Depreciation	2.15	2.13	1.31	1.14	1.17	1.25	0.48	0.00
Profit before tax	2.69	-1.07	1.75	5.71	2.70	-2.27	0.10	-1.61
Tax %	49.07%	-18.69%	-16.57%	37.30%	32.59%	-3.52%	-100.00%
Net Profit	1.36	-0.86	2.05	3.57	1.83	-2.19	0.20	-2.36
EPS in Rs	1.94	-1.23	2.93	5.10	1.74	-2.09	0.19	-2.25
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-163.24%	338.37%	74.15%	-48.74%	-219.67%	109.13%
Change in YoY Net Profit Growth (%)	0.00%	501.61%	-264.23%	-122.89%	-170.93%	328.80%

Global Longlife Hospital and Research Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	-61%
3 Years:	-79%
TTM:	-98%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-119%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	-33%
1 Year:	-41%

Return on Equity
10 Years:	%
5 Years:	1%
3 Years:	-4%
Last Year:	-18%

Last Updated: September 5, 2025, 3:36 pm

Balance Sheet

Last Updated: February 1, 2026, 2:52 am

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	7.00	7.00	7.00	7.00	10.50	10.50	10.50	10.50
Reserves	5.35	4.49	6.68	9.96	53.79	15.43	16.29	14.97
Borrowings	27.18	23.51	17.04	8.69	9.29	12.74	0.00	0.00
Other Liabilities	3.77	6.92	6.06	8.33	2.36	3.07	0.06	0.01
Total Liabilities	43.30	41.92	36.78	33.98	75.94	41.74	26.85	25.48
Fixed Assets	20.17	18.72	17.46	16.71	16.52	17.27	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	1.03	0.00	0.00	0.00
Investments	0.10	0.10	0.47	0.10	0.10	0.03	0.03	0.00
Other Assets	23.03	23.10	18.85	17.17	58.29	24.44	26.82	25.48
Total Assets	43.30	41.92	36.78	33.98	75.94	41.74	26.85	25.48

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	5.40	3.90	6.88	9.42	-40.42	-5.07	12.32
Cash from Investing Activity +	-0.33	-0.04	0.02	0.01	-1.90	-0.82	21.80
Cash from Financing Activity +	-4.77	-3.05	-7.22	-9.66	45.70	2.67	-13.01
Net Cash Flow	0.31	0.81	-0.33	-0.22	3.38	-3.22	21.11
Free Cash Flow	5.00	3.79	6.84	8.96	-42.42	-6.10	33.42
CFO/OP	79%	113%	126%	105%	-960%	2,259%	-304%

Free Cash Flow

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-20.35	-20.07	-11.60	-0.39	-5.21	-12.96	-4.14

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	94.85	68.68	87.51	100.25	151.43	52.88	376.77
Inventory Days	169.49	157.97	34.46	88.98	69.12	131.64	0.00
Days Payable	229.91	391.69	138.68	432.74	110.43	765.90
Cash Conversion Cycle	34.44	-165.03	-16.71	-243.52	110.13	-581.38	376.77
Working Capital Days	19.21	12.16	7.14	-29.70	344.86	-238.36	1,283.39
ROCE %		3.81%	12.75%	26.22%	6.35%	-2.51%	-13.69%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	54.29%	54.29%	54.29%	54.29%	54.29%	54.29%	54.29%	54.29%	54.29%	54.90%	55.10%	35.44%
Public	45.71%	45.71%	45.72%	45.71%	45.71%	45.72%	45.73%	45.72%	45.70%	45.10%	44.91%	64.56%
No. of Shareholders	888	889	880	935	947	1,010	974	989	938	917	915	985

Shareholding Pattern Chart

No. of Shareholders

Global Longlife Hospital and Research Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.19	-2.08	1.79	5.11	2.92
Diluted EPS (Rs.)	0.19	-2.08	1.79	5.11	2.92
Cash EPS (Rs.)	0.64	-0.89	2.85	6.74	5.61
Book Value[Excl.RevalReserv]/Share (Rs.)	25.51	24.70	61.23	24.23	19.54
Book Value[Incl.RevalReserv]/Share (Rs.)	25.51	24.70	61.23	24.23	19.54
Revenue From Operations / Share (Rs.)	0.54	12.87	22.38	46.88	46.72
PBDIT / Share (Rs.)	0.81	-0.23	4.07	11.79	8.67
PBIT / Share (Rs.)	0.35	-1.43	2.96	10.15	5.98
PBT / Share (Rs.)	0.09	-2.16	2.58	8.16	2.51
Net Profit / Share (Rs.)	0.18	-2.08	1.74	5.11	2.92
PBDIT Margin (%)	148.50	-1.83	18.18	25.14	18.56
PBIT Margin (%)	65.02	-11.08	13.22	21.66	12.81
PBT Margin (%)	17.18	-16.76	11.52	17.40	5.37
Net Profit Margin (%)	34.41	-16.19	7.77	10.89	6.25
Return on Networth / Equity (%)	0.74	-8.43	2.84	21.06	14.96
Return on Capital Employeed (%)	1.40	-5.09	4.56	35.19	15.94
Return On Assets (%)	0.74	-5.24	2.40	10.51	5.56
Long Term Debt / Equity (X)	0.00	0.13	0.05	0.16	0.91
Total Debt / Equity (X)	0.00	0.49	0.14	0.51	0.91
Asset Turnover Ratio (%)	0.01	0.22	0.42	0.92	0.85
Current Ratio (X)	405.69	0.31	4.28	0.82	1.13
Quick Ratio (X)	405.69	0.28	4.17	0.75	1.06
Inventory Turnover Ratio (X)	2.64	0.00	0.00	0.00	0.00
Interest Coverage Ratio (X)	3.10	-0.32	10.67	5.90	2.50
Interest Coverage Ratio (Post Tax) (X)	1.72	-1.85	5.56	3.55	1.84
Enterprise Value (Cr.)	-1.58	53.35	52.71	0.00	0.00
EV / Net Operating Revenue (X)	-2.74	3.95	2.24	0.00	0.00
EV / EBITDA (X)	-1.85	-215.57	12.33	0.00	0.00
MarketCap / Net Operating Revenue (X)	34.48	3.03	2.00	0.00	0.00
Price / BV (X)	0.74	1.58	0.73	0.00	0.00
Price / Net Operating Revenue (X)	34.54	3.03	2.00	0.00	0.00
EarningsYield	0.01	-0.05	0.03	0.00	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Global Longlife Hospital and Research Ltd. is a Public Limited Listed company incorporated on 20/01/2012 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L85110GJ2012PLC068700 and registration number is 068700. Currently company belongs to the Industry of Hospitals & Medical Services. Company's Total Operating Revenue is Rs. 0.58 Cr. and Equity Capital is Rs. 10.50 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	703, Sankalp Square, 3B, Beside Taj Skyline, Sindhu Bhavan Road, Ahmedabad Gujarat 380059	Contact not found

Management
Name	Position Held
Mr. Dhruv Jani	Managing Director
Ms. Hetal Thakkar	Executive Director & CFO
Mrs. Sucheta Jani	Non Executive Director
Mr. Manasvi Thapar	Independent Director
Mr. Sandeep Shah	Independent Director

FAQ

What is the intrinsic value of Global Longlife Hospital and Research Ltd and is it undervalued?

As of 23 April 2026, Global Longlife Hospital and Research Ltd's intrinsic value is ₹14.86, which is 3.92% higher than the current market price of ₹14.30, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (17.7 %), book value (₹24.3), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Global Longlife Hospital and Research Ltd?

Global Longlife Hospital and Research Ltd is trading at ₹14.30 as of 23 April 2026, with a FY2026-2027 high of ₹33.0 and low of ₹11.6. The stock is currently near its 52-week low. Market cap stands at ₹15.0 Cr..

How does Global Longlife Hospital and Research Ltd's P/E ratio compare to its industry?

Global Longlife Hospital and Research Ltd has a P/E ratio of , which is below the industry average of 75.17. This is broadly in line with or below the industry average.

Is Global Longlife Hospital and Research Ltd financially healthy?

Key indicators for Global Longlife Hospital and Research Ltd: ROCE of 13.7 % is moderate; ROE of 17.7 % shows strong shareholder returns. Dividend yield is 0.00 %.

Is Global Longlife Hospital and Research Ltd profitable and how is the profit trend?

Global Longlife Hospital and Research Ltd reported a net profit of ₹0 Cr in Mar 2025 on revenue of ₹0 Cr. Compared to ₹4 Cr in Mar 2022, the net profit shows a declining trend.

Does Global Longlife Hospital and Research Ltd pay dividends?

Global Longlife Hospital and Research Ltd has a dividend yield of 0.00 % at the current price of ₹14.30. The company is currently not paying meaningful dividends.